Robert C. Armstrong
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Cell death mechanisms and regulation, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Distributed and Parallel Computing Systems
Most-Cited Works
- → An inhibitor of Bcl-2 family proteins induces regression of solid tumours(2005)3,369 cited
- → A mechanistic role for cardiac myocyte apoptosis in heart failure(2003)739 cited
- → In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.(1996)732 cited
- → AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)(2009)638 cited
- → Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis(1997)437 cited
- → Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer(2004)364 cited
- → Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status(2013)360 cited
- → Cell-specific Induction of Apoptosis by Microinjection of Cytochrome c(1997)352 cited
- → FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis(1997)335 cited
- → Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors(1996)319 cited